Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis – FUTURE ONCOLOGY

Carles, J; Medina-Lopez, RA; Puente, J; Gomez-Ferrer, A; Nebra, JC; Medina, MIS; Ribal, MJ; Antolin, AR; Alvarez-Ossorio, JL; Novo, JFS; Agut, CM; Srinivasan, S; Ortiz, J; Fizazi, K – 2023 – 10.2217/fon-2022-1131